SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0000950123-10-037663
Filing Date
2010-04-23
Accepted
2010-04-23 16:26:58
Documents
11
Period of Report
2010-06-04
Effectiveness Date
2010-04-23

Document Format Files

Seq Description Document Type Size
1 DEF 14A b79918def14a.htm DEF 14A 525270
2 GRAPHIC b79918b7991800.gif GRAPHIC 953
3 GRAPHIC b79918b7991801.gif GRAPHIC 2101
4 GRAPHIC b79918b7991802.gif GRAPHIC 2601
5 GRAPHIC b79918b7991803.gif GRAPHIC 9520
6 GRAPHIC b79918b7991804.gif GRAPHIC 1386
7 GRAPHIC b79918b7991805.gif GRAPHIC 6372
8 GRAPHIC b79918b7991806.gif GRAPHIC 786
9 GRAPHIC b79918b7991807.gif GRAPHIC 814
10 GRAPHIC b79918b7991808.gif GRAPHIC 2106
11 GRAPHIC b79918b7991809.gif GRAPHIC 10120
  Complete submission text file 0000950123-10-037663.txt   578795
Mailing Address 60 PRESCOTT STREET WORCESTER MA 01605
Business Address 60 PRESCOTT STREET WORCESTER MA 01605 508-767-3861
RXI PHARMACEUTICALS CORP (Filer) CIK: 0001390478 (see all company filings)

IRS No.: 000000000
Type: DEF 14A | Act: 34 | File No.: 001-33958 | Film No.: 10767553
SIC: 2834 Pharmaceutical Preparations